Publications by authors named "Christopher A Mecoli"

Claim this Profile
P
Patient-Reported Outcomes in Myositis.
Jin Kyun Park, Christopher A Mecoli

Rheum Dis Clin North Am· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of risk factors for incident left ventricular systolic dysfunction and predictors of cardiac recovery in patients with systemic sclerosis.
Ji Soo Kim, Rachel S Wallwork, Carrie Richardson, Adrianne Woods, Monica Mukherjee, Christopher A Mecoli

Arthritis Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the classification and management of idiopathic inflammatory myopathies.
Joost Raaphorst, Anneke J van der Kooi, Christopher A Mecoli, Conrad C Weihl, Sander W Tas

Lancet Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Pulmonary Function Test Reference Equations on Classification of Restrictive Lung Disease Severity in Systemic Sclerosis.
Kamini E Kuchinad, Rachel S Wallwork, Matthew R Lammi, Christopher A Mecoli, Julie J Paik

Arthritis Care Res (Hoboken)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Adult Patients With Dermatomyositis Using Real-World Data Sources.
Benjamin Martin, Will Kelly, Hannah Morgan-Cooper, Thomas Falconer, Elizabeth Park, Christopher A Mecoli

Arthritis Care Res (Hoboken)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases.
Samuel D Curtis, Tingshan Liu, Yuxin Bai, Yuxuan Wang, Sambit Panda, Christopher A Mecoli

Proc Natl Acad Sci U S A· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-TRIM72 Autoantibodies in Idiopathic Inflammatory Myopathies.
Eugene Krustev, Tiara N Safaei, Daniela Trejo-Zambrano, Lisa Christopher-Stine, Andrew Mammen, Christopher A Mecoli

medRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis.
Jamie Perin, Michael Hughes, Christopher A Mecoli, Julie J Paik, Allan C Gelber

Rheumatology (Oxford)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographics and clinical features associated with abnormal small bowel motility in systemic sclerosis.
Jenice X Cheah, Jamie Perin, Michael Hughes, Christopher A Mecoli, Julie J Paik

Rheumatology (Oxford)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies.
XingYao Wang, Jemima Albayda, Julie J Paik, Eleni Tiniakou, Brittany Adler, Christopher A Mecoli

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy.
Eleni Tiniakou, Alex Girgis, Tiara Siafei, Jemima Albayda, Brittany Adler, Christopher A Mecoli

Ann Rheum Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and Clinical Implications of Misdiagnosis in Dermatomyositis.
Aaron Bao, Saloni Patel, Christopher A Mecoli, William Kelly, Jemima Albayda

JAMA Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Relationship Between Anti-Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti-Sp4 Autoantibodies, and Cancer in Anti-Transcription Intermediary Factor 1γ-Positive Dermatomyositis.
Christopher A Mecoli, David Fiorentino, Jemima Albayda, Julie J Paik, Eleni Tiniakou

ACR Open Rheumatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group.
Ellen Romich, Didem Saygin, Dana DiRenzo, Christopher A Mecoli, Ingrid de Groot

Semin Arthritis Rheum· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group.
Didem Saygin, Helene Alexanderson, Dana DiRenzo, Joost Raaphorst, Marianne de Visser, Christopher A Mecoli

Semin Arthritis Rheum· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collaborative research in myositis-related disorders: MIHRA, a global shared community model.
Lesley Ann Saketkoo, Julie J Paik, Helene Alexanderson, Mazen M Dimachkie, Floranne C Ernste, Christopher A Mecoli

Clin Exp Rheumatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis Against Pneumocystis Pneumonia.
Avrom S Caplan, Christopher A Mecoli, Robert G Micheletti

JAMA· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Yield of Computed Tomography for Cancer Detection in a Tertiary Referral Population of Idiopathic Inflammatory Myositis Patients.
Christopher A Mecoli, Brant Chee, Mengkun Chen, XingYao Wang, Jemima Albayda

Arthritis Care Res (Hoboken)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bullous periorbital oedema in anti-p155/140-positive dermatomyositis: a case series.
Caoilfhionn M Connolly, Lillian Xu, Christopher A Mecoli, Brittany L Adler, Eleni Tiniakou

Rheumatology (Oxford)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocarditis in Patients With Idiopathic Inflammatory Myopathies: Clinical Presentation and Outcomes.
Melody P Chung, Jana Lovell, William Kelly, Christopher A Mecoli, Jemima Albayda

J Rheumatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Anti-CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti-Transcriptional Intermediary Factor 1γ-Positive Dermatomyositis.
David Fiorentino, Christopher A Mecoli, Tak Igusa, Jemima Albayda, Julie J Paik

Arthritis Rheumatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis.
Elizabeth Harlan Michelle, Iago Pinal-Fernandez, Maria Casal-Dominguez, Jemima Albayda, Julie J Paik, Christopher A Mecoli

Neurology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-MDA5-positive dermatomyositis and remission in a single referral centre population.
Eleni Tiniakou, Christopher A Mecoli, William Kelly, Jemima Albayda, Julie J Paik

Clin Exp Rheumatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies.
Yuji Hosono, Brandon Sie, Iago Pinal-Fernandez, Katherine Pak, Christopher A Mecoli

Ann Rheum Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group.
Dana DiRenzo, Didem Saygin, Ingrid de Groot, Clifton O Bingham Iii, Ingrid E Lundberg, Christopher A Mecoli

Semin Arthritis Rheum· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis